STOCK TITAN

Leader's Advantage closes $6.5M additional unit sale

After the partial option exercise, the offering totaled 15,650,000 units and $156,500,000 in gross proceeds before discounts and estimated expenses.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Leader’s Advantage Acquisition Corp. (LEDRU) closed the sale of 650,000 additional units on October 29, 2026, at $10.00 per unit, generating $6,500,000 in gross proceeds. Underwriters partially exercised the over-allotment option on October 27, 2026. After the sale, the offering totaled 15,650,000 units, with total gross proceeds of $156,500,000 before underwriting discounts and estimated offering expenses.

Each unit consists of one Class A ordinary share and one-half of one redeemable warrant; each whole warrant entitles its holder to purchase one Class A ordinary share for $11.50 per share. The company said its primary focus would be a healthcare-focused business combination and stated there was no assurance it would complete a transaction in its target sector or at all.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Additional units sold 650,000 units Closed October 29, 2026, following partial exercise of the over-allotment option.
Price per unit $10.00 per unit Price for the additional units.
Additional gross proceeds $6,500,000 Gross proceeds generated by the sale of the additional units.
Total units sold 15,650,000 units Total units sold in the offering after the partial option exercise.
Total gross proceeds $156,500,000 Before underwriting discounts and estimated offering expenses.
Warrant exercise price $11.50 per share Each whole warrant entitles its holder to purchase one Class A ordinary share.
Initial public offering units 15,000,000 units Units sold in the initial public offering before the over-allotment closing.
over-allotment option financial
"partial exercise of the underwriter’s over-allotment option"
An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.
gross proceeds financial
"resulting in additional gross proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.
redeemable warrant financial
"one-half of one redeemable warrant"
A redeemable warrant is a financial tool that gives its holder the right to buy shares of a company at a fixed price within a certain period. If the holder chooses to do so, the company can buy back or cancel the warrant before it expires, often to encourage investment or manage share issuance. For investors, it provides an option to potentially buy shares at a favorable price while offering some flexibility for the issuing company.
underwriting discounts financial
"before deducting underwriting discounts"
The portion of a securities offering that underwriters keep as payment for arranging and selling the issue, often expressed as the gap between what the issuer receives and the price paid by public investors. It matters to investors because it reduces the net proceeds the company raises and signals how much institutional middlemen are charging — like a broker’s commission — which can affect a deal’s economics and the degree of dilution for existing shareholders.
business combination financial
"completing a healthcare-focused business combination"
A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many additional units did LEDRU sell through its over-allotment option?

LEDRU sold 650,000 additional units at $10.00 per unit, generating $6,500,000 in gross proceeds. The sale closed October 29, 2026, after the underwriters partially exercised the over-allotment option.

How many units did LEDRU sell in total, and what were the gross proceeds?

After the partial exercise, the offering totaled 15,650,000 units and generated $156,500,000 in gross proceeds before underwriting discounts and estimated offering expenses. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0002109823 0002109823 2026-10-27 2026-10-27 0002109823 LEDRU:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember 2026-10-27 2026-10-27 0002109823 LEDRU:ClassOrdinarySharesParValue0.0001PerShareMember 2026-10-27 2026-10-27 0002109823 LEDRU:RedeemableWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtPriceOf11.50PerShareMember 2026-10-27 2026-10-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 27, 2026

 

Leader’s Advantage Acquisition Corp. 

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-43442   98-1898982
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1288 NJ-73, Suite 401,

Mt Laurel Township, NJ 08054

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (856) 533-1866

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant   LEDRU   The Nasdaq Stock Market LLC
Class A Ordinary Shares, par value $0.0001 per share   LEDR   The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one Class ordinary share at a price of $11.50 per share   LEDRW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01. Other Events.

 

As previously disclosed, on September 21, 2026, Leader’s Advantage Acquisition Corp. (the “Company”) consummated its initial public offering (“IPO”) of 15,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share, $0.0001 par value (“Class A Ordinary Share”), and one-half of one redeemable warrant of the Company (each, a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share.

 

On October 27, 2026, the underwriters partially exercised their over-allotment option (the “Over-Allotment Option”) to purchase an additional 650,000 Units (the “Option Units”) at a price of $10.00 per Option Unit. The closing of the issuance and sale of the Option Units occurred on October 29, 2026. The sale of the Option Units generated total gross proceeds to the Company of $6,500,000.

 

On October 29, 2026, the Company issued a press release announcing the closing of the partial exercise of the Over-Allotment Option, a copy of which is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01 Exhibits.

 

(d) Exhibits.

 

99.1   Press Release, dated October 29, 2026.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document). 

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Leader’s Advantage Acquisition Corp.
     
  By: /s/ Dr. Paritosh M. Chakrabarti
    Name: Dr. Paritosh Chakrabarti
    Title: Chairman and Chief Executive Officer
     
Dated: October 30, 2026    

 

2

Exhibit 99.1

 

Leader’s Advantage Acquisition Corp. Announces Closing of Partial Exercise of Over-Allotment Option in Connection with its Initial Public Offering

 

Mt. Laurel Township, NJ, Oct. 29, 2026 (GLOBE NEWSWIRE) --  Leader’s Advantage Acquisition Corp. (the “Company”) a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today that it closed the sale of an additional 650,000 units of the Company, pursuant to the partial exercise of the underwriter’s over-allotment option granted in connection with the Company’s initial public offering (together with the over-allotment closing, the “Offering”), at the price of $10.00 per unit, resulting in additional gross proceeds of approximately $6,500,000.

 

After giving effect to this partial exercise of the over-allotment option, the total number of units sold in the Offering increased to 15,650,000 units, resulting in total gross proceeds of $156,500,000, before deducting underwriting discounts and estimated offering expenses.

 

The Company’s units began trading on September 18, 2026 on the Nasdaq Global Market (“Nasdaq”) under the ticker symbol “LEDRU.” Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “LEDR” and “LEDRW,” respectively.

 

The Company’s primary focus will be completing a healthcare-focused business combination with an established business of scale along with first-in-class drug candidates with large addressable markets poised for continued growth, led by a highly regarded management team, that the Company’s management believes would benefit from financial, operational, strategic or managerial enhancement to maximize value.

 

The Company’s management team is led by Dr. Paritosh M. Chakrabarti, Chairman and Chief Executive Officer, Dr. Raj Chakrabarti, President, and Edward Krynski, Chief Financial Officer.

 

Clear Street LLC acted as lead book-running manager and D. Boral Capital LLC acted as bookrunner for the Offering. 

 

A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on September 17, 2026. The Offering was made only by means of a prospectus. Copies of the final prospectus relating to the Offering may be obtained from: Clear Street LLC, Attn: Syndicate Department, 150 Greenwich Street, 45th Floor, New York, NY 10007, or via email at ecm@clearstreet.io and D. Boral Capital LLC, 590 Madison Avenue, 39th Floor, New York, NY 10022, or via email at dbccapitalmarkets@dboralcapital.com.

 

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

Forward-Looking Statements 

 

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated use of the net proceeds from the Offering and the Company's expectations regarding its ability to complete a business combination. No assurance can be given that the Company will ultimately complete a business combination transaction in the sector it is targeting, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the Offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

 

Media Contact:

 

Paul Weiss
pweiss@pmc-group.com

 

 

Filing Exhibits & Attachments

5 documents

Keep reading